PMID- 38292460
OWN - NLM
STAT- MEDLINE
DCOM- 20240201
LR  - 20240206
IS  - 1178-1998 (Electronic)
IS  - 1176-9092 (Print)
IS  - 1176-9092 (Linking)
VI  - 19
DP  - 2024
TI  - Imaging of Sarcopenia in Type 2 Diabetes Mellitus.
PG  - 141-151
LID - 10.2147/CIA.S443572 [doi]
AB  - Sarcopenia is an age-related condition characterized by the loss of skeletal 
      muscle mass, muscular strength, and muscle function. In older adults, type 2 
      diabetes mellitus (T2DM) constitutes a significant health burden. Skeletal muscle 
      damage and deterioration have emerged as novel chronic complications in patients 
      with diabetes, often linked to their increased longevity. Diabetic sarcopenia has 
      been associated with increased rates of hospitalization, cardiovascular events, 
      and mortality. Nevertheless, effectively managing metabolic disorders in patients 
      with T2DM through appropriate therapeutic interventions could potentially 
      mitigate the risk of sarcopenia. Utilizing imaging technologies holds substantial 
      clinical significance in the early detection of skeletal muscle mass alterations 
      associated with sarcopenia. Such detection is pivotal for arresting disease 
      progression and preserving patients' quality of life. These imaging modalities 
      offer reproducible and consistent patterns over time, as they all provide varying 
      degrees of quantitative data. This review primarily delves into the application 
      of dual-energy X-ray absorptiometry, computed tomography, magnetic resonance 
      imaging, and ultrasound for both qualitative and quantitative assessments of 
      muscle mass in patients with T2DM. It also juxtaposes the merits and limitations 
      of these four techniques. By understanding the nuances of each method, clinicians 
      can discern how best to apply them in diverse clinical scenarios.
CI  - (c) 2024 Wang et al.
FAU - Wang, Dingyue
AU  - Wang D
AD  - Department of Ultrasound, the First Affiliated Hospital China Medical University, 
      Shenyang City, Liaoning Province, 110001, People's Republic of China.
FAU - Zhang, Gaosen
AU  - Zhang G
AD  - Department of Ultrasound, the First Affiliated Hospital China Medical University, 
      Shenyang City, Liaoning Province, 110001, People's Republic of China.
FAU - Yu, Yana
AU  - Yu Y
AD  - Department of Ultrasound, the First Affiliated Hospital China Medical University, 
      Shenyang City, Liaoning Province, 110001, People's Republic of China.
FAU - Zhang, Zhen
AU  - Zhang Z
AD  - Department of Ultrasound, the First Affiliated Hospital China Medical University, 
      Shenyang City, Liaoning Province, 110001, People's Republic of China.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20240126
PL  - New Zealand
TA  - Clin Interv Aging
JT  - Clinical interventions in aging
JID - 101273480
SB  - IM
MH  - Humans
MH  - Aged
MH  - *Sarcopenia/diagnostic imaging/etiology
MH  - *Diabetes Mellitus, Type 2/complications/diagnostic imaging
MH  - Muscle, Skeletal/pathology
MH  - Quality of Life
MH  - Muscle Strength/physiology
PMC - PMC10826713
OTO - NOTNLM
OT  - diagnostic imaging
OT  - older adults
OT  - sarcopenia
OT  - skeletal muscle mass
OT  - type 2 diabetes mellitus
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2024/01/31 06:43
MHDA- 2024/02/01 06:42
PMCR- 2024/01/26
CRDT- 2024/01/31 04:11
PHST- 2023/10/07 00:00 [received]
PHST- 2024/01/17 00:00 [accepted]
PHST- 2024/02/01 06:42 [medline]
PHST- 2024/01/31 06:43 [pubmed]
PHST- 2024/01/31 04:11 [entrez]
PHST- 2024/01/26 00:00 [pmc-release]
AID - 443572 [pii]
AID - 10.2147/CIA.S443572 [doi]
PST - epublish
SO  - Clin Interv Aging. 2024 Jan 26;19:141-151. doi: 10.2147/CIA.S443572. eCollection 
      2024.